Cardiac Arrhythmia Monitoring Devices Market Report 2026

Cardiac Arrhythmia Monitoring Devices Market Overview

• Cardiac Arrhythmia Monitoring Devices market size has reached to $8.37 billion in 2025 • Expected to grow to $13.16 billion in 2030 at a compound annual growth rate (CAGR) of 9.4% • Growth Driver: Rising Prevalence Of Cardiovascular Diseases To Drive Market Growth • Market Trend: Product Innovations Transforming The Cardiac Arrhythmia Monitoring Devices Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cardiac Arrhythmia Monitoring Devices Market?

The cardiac arrhythmia monitoring device is a device used for monitoring the arrhythmia (irregular beating) condition of the heart. The main types of cardiac arrhythmia monitoring devices are: standards in ambulatory cardiac monitoring, patient- and event-activated intermittent recorders, external loop recorders, pre-symptom memory loop cardiac event recorders, post-symptom event recorders, continuous real-time attended remote cardiac monitors, mobile cardiac outpatient telemetry systems, and vital signs transmitters such as Bio Watch Medical. The standards in ambulatory cardiac monitoring refer to recording and detecting the electrical activity in a patient’s heart over longer periods, which is used in diagnosing arrhythmias such as irregular heart rhythms. The devices include the Holter monitor, event recorder, mobile cardiac telemetry, implantable cardiac monitor, electrocardiogram (ECG) monitor, and others applied for the detection of tachycardia, bradycardia, premature contraction, and others, used by hospitals and clinics, diagnostic centers, ambulatory surgical centers, homecare settings, and others.

What Is The Cardiac Arrhythmia Monitoring Devices Market Growth Forecast?

The cardiac arrhythmia monitoring devices market size is expected to see strong growth in the next few years. It will grow to $13.16 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to increasing demand for remote patient monitoring, rising investments in digital health platforms, expansion of ai-enabled arrhythmia detection, growing preference for homecare diagnostics, increasing integration with mobile health ecosystems. Major trends in the forecast period include increasing adoption of wearable cardiac monitoring devices, rising use of remote and home-based monitoring, growing integration of real-time data analytics, expansion of implantable monitoring solutions, enhanced focus on continuous long-term monitoring.

Global Cardiac Arrhythmia Monitoring Devices Market Segmentation

1) By Type: Standards in Ambulatory Cardiac Monitoring, Patient- and Event-activated Intermittent Recorders, External Loop Recorder, Continuous Real-time Attended Remote Cardiac Monitors, Mobile Cardiac Outpatient Telemetry System 2) By Device: Holter Monitor, Event Recorder, Mobile Cardiac Telemetry, Implantable Cardiac Monitor, Electrocardiogram (ECG) Monitor, Other Devices 3) By Application: Tachycardia, Bradycardia, Premature Contraction, Other Applications 4) By End-use: Hospitals and Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Homecare Settings, Other End-uses Subsegments: 1) By Standards In Ambulatory Cardiac Monitoring: Holter Monitors, Mobile Cardiac Telemetry (MCT), Event Monitors 2) By Patient- And Event-Activated Intermittent Recorders: Handheld Recorders, Wearable Event Monitors 3) By External Loop Recorder: Pre-Symptom Memory Loop Cardiac Event Recorder, Post-Symptom Event Recorder 4) By Continuous Real-Time Attended Remote Cardiac Monitors: Hospital-Based Monitors, Home-Based Monitors 5) By Mobile Cardiac Outpatient Telemetry System: Wireless Telemetry Systems, Real-Time Data Transmission Devices

What Is The Driver Of The Cardiac Arrhythmia Monitoring Devices Market?

The growing prevalence of cardiovascular diseases is expected to propel the growth of the cardiac arrhythmia monitoring devices market going forward. Cardiovascular diseases refer to the group of diseases associated with conditions affecting the heart and blood vessels such as atherosclerosis, angina, heart attacks, aortic disease, and others. In cardiovascular diseases, cardiac arrhythmia monitoring devices help in event monitoring to keep track of the electrical activity of a patient’s heart rhythm and beat (ECG) and detect or determine the risk of irregular heartbeats (arrhythmias). For instance, in April 2023, according to HMP Global, a US-based multi-accredited patient-centered education company, it is projected that the prevalence of peripheral arterial disease in the US will reach 23.8 million in 2030, from 21.0 million in 2020. Therefore, the growing prevalence of cardiovascular diseases is driving the growth of the cardiac arrhythmia monitoring devices industry.

Key Players In The Global Cardiac Arrhythmia Monitoring Devices Market

Major companies operating in the cardiac arrhythmia monitoring devices market are AliveCor Inc., Biotronik SE & Co. KG, General Electric Company, iRhythm Technologies Inc., Koninklijke Philips N.V., Medtronic PLC, Nihon Kohden Corporation, Abbott Laboratories, Hill-Rom Holdings Inc., Applied Cardiac System Diagnostics Inc., Biotricity Inc., Boston Scientific Corporation, Medicalgorithmics S.A., Siemens AG, Fukuda Denshi Co. Ltd., NUUBO SMART SOLUTIONS S.L., Cardiac Insight Inc., CardioComm Solutions Inc., MicroPort Scientific Corporation, Osypka AG, Spacelabs Healthcare

Global Cardiac Arrhythmia Monitoring Devices Market Trends and Insights

Major companies operating in the cardiac arrhythmia monitoring devices market are developing new insertable cardiac monitoring systems to sustain their position in the market. Insertable cardiac monitoring systems are small, implantable devices that continuously monitor and record the heart's electrical activity, providing long-term diagnostic data for the detection of cardiac arrhythmias and other cardiovascular conditions. For instance, in October 2023, Boston Scientific Corporation, a US-based medical equipment manufacturing company, launched the LUX-Dx II+ Insertable Cardiac Monitor System, a device designed for long-term monitoring of arrhythmias. It includes dual-stage algorithms for detecting and verifying potential arrhythmias before alerting clinicians, remote programming capabilities, and programmable algorithms for identifying various cardiac conditions. The device offers enhanced diagnostic capabilities with a focus on rejecting false positives and irrelevant episodes. Patients benefit from a downloadable app for convenient remote monitoring.

What Are Latest Mergers And Acquisitions In The Cardiac Arrhythmia Monitoring Devices Market?

In May 2024, WearLinq, a US-based digital healthcare company, acquired AMI Cardiac Monitoring for an undisclosed amount. Through this acquisition, WearLinq aims to significantly enhance the company's capacity to provide clinical services. AMI Cardiac Monitoring is a US-based independent diagnostic testing facility (IDTF) company, provides cardiac arrhythmia monitoring devices for patients wanting the assurance.

Regional Outlook

North America was the largest region in the cardiac arrhythmia monitoring devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the cardiac arrhythmia monitoring devices market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Cardiac Arrhythmia Monitoring Devices Market?

The cardiac arrhythmia monitoring devices market consists of sales of wireless holter monitors, post-event recorder patch recorders, autodetect recorders, implanted loop recorders, remote monitoring of pacemakers, implantable cardioverter-defibrillators, real-time telemetry devices, and insertable loop recorders. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.